Natural Product: NPC470396

Natural Product IDNPC470396
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
3Beta,21Alpha-Dihidroxy-Olean-18-Ene
IUPAC Name (3S,4aR,6aS,6aR,6bR,8aS,10R,14aR,14bR)-4,4,6a,6b,8a,11,11,14b-octamethyl-1,2,3,4a,5,6,6a,7,8,9,10,13,14,14a-tetradecahydropicene-3,10-diol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL2023098
PubChem CID 60145807
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey KFRKENQBMHZDTC-GCKMCXAPSA-N
Standard InCHI InChI=1S/C30H50O2/c1-25(2)17-20-19-9-10-22-28(6)13-12-23(31)26(3,4)21(28)11-14-30(22,8)29(19,7)16-15-27(20,5)18-24(25)32/h17,19,21-24,31-32H,9-16,18H2,1-8H3/t19-,21+,22-,23+,24-,27+,28+,29-,30-/m1/s1
SMILES CC1(C=C2C3CCC4C5(CCC(C(C5CCC4(C3(CCC2(CC1O)C)C)C)(C)C)O)C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   442.38 Volume:   499.598
?
Van der Waals volume.
Dense:   0.885 LogP:   5.021
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   4.483
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.878
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   0.0 Rigid Bonds:   26.0
TPSA:   40.46
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   2.0 Rings:   5.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.391 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.914 Fsp3:   0.933
MCE-18:   104.897
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.345 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.035
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.512 Promiscuous compounds:   0.01

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.911 MDCK Permeability:   -4.749
Pgp-inhibitor:   0.001 Pgp-substrate:   0.209
PAMPA:   0.768
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.002
20% Bioavailability (F20%):   0.042 30% Bioavailability (F30%):   0.054
50% Bioavailability (F50%):   0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.881 MRP1:   0.999
Plasma Protein Binding (PPB):   84.292% Volume Distribution (VD):   -0.088
Fu: 11.654%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.03
OATP1B3 inhibitor:   0.971 BCRP inhibitor:   0.004
BSEP inhibitor:   0.782

ADMET: Metabolism

CYP1A2-inhibitor:   0.751 CYP1A2-substrate:   0.017
CYP2C19-inhibitor:   0.998 CYP2C19-substrate:   0.065
CYP2C9-inhibitor:   0.363 CYP2C9-substrate:   0.024
CYP2D6-inhibitor:   0.977 CYP2D6-substrate:   0.069
CYP3A4-inhibitor:   0.929 CYP3A4-substrate:   0.0
CYP2B6-substrate:   1.0 CYP2C8-inhibitor:   0.88
HLM stability:   0.989
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  18.342 Half-life (T1/2):  0.866

ADMET: Toxicity

hERG Blockers:  0.314 hERG Blockers (10um):  0.824
Human Hepatotoxicity (H-HT):  0.365 Drug-induced Liver Injury (DILI):  0.034
AMES Toxicity:  0.091 Rat Oral Acute Toxicity:  0.199
Maximum Recommended Daily Dose:  0.902 Skin Sensitization:  0.09
Carcinogencity:  0.368 Eye Corrosion:  0.003
Eye Irritation:  0.257 Respiratory Toxicity:  0.835
Drug-induced Neurotoxicity:  0.381 Ototoxicity:  0.902
Hematotoxicity:  0.086 Drug-induced Nephrotoxicity:  0.07
Genotoxicity:  0.001 RPMI-8226 Immunitoxicity:  0.047
A549 Cytotoxicity:  0.471 Hek293 Cytotoxicity:  0.513
BCF:   2.394
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.231
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.333
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   6.199
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33201 celastraceae sp. Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[22487595]
NPO33201 celastraceae sp. Species Celastraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT460 Cell line MT2 Homo sapiens Activity = 69.0 % DOI[10.1016/0960-894X(95)00326-O]
NPT460 Cell line MT2 Homo sapiens CC50 > 100000.0 nM PMID[23859780]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 Inhibition = 18.0 % PMID[25124114]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 = 64360.0 nM PubChem BioAssay data set
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 = 54280.0 nM PMID[27161176]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 Inhibition < 50.0 % PMID[25668494]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC470396 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7959 Intermediate Similarity NPC265328
0.7647 Intermediate Similarity NPC99168
0.6909 Remote Similarity NPC180834
0.6071 Remote Similarity NPC300499
0.5965 Remote Similarity NPC471737
0.5789 Remote Similarity NPC157996
0.5439 Remote Similarity NPC242350
0.5167 Remote Similarity NPC69627
0.5156 Remote Similarity NPC181225
0.5085 Remote Similarity NPC144075

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470396 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data